Conference Coverage

VIDEO: How to recognize and treat nonalcoholic fatty liver disease



PHILADELPHIA – Nonalcoholic fatty liver disease is on the rise worldwide, but many clinicians are unaware of how to recognize this potentially fatal condition, in part because it can be difficult to separate from common comorbidities such as obesity and diabetes.

In an interview at the Digestive Diseases: New Advances 2016 meeting, held by Global Academy for Medical Education and Rutgers, the State University of New Jersey, Dr. Zobair M. Younossi, chairman of the department of medicine at Inova Fairfax (Va.) Hospital, discussed what clinicians should know in order to screen for and treat this disease.

Dr. Younossi said he is a consultant to Conatus Pharmaceuticals, Enterome Bioscience, and Gilead, and on the advisory boards of Janssen, Salix Pharmaceuticals, and Vertex Pharmaceuticals.

Global Academy and this news organization are owned by the same company.

On Twitter @whitneymcknight

Recommended Reading

VIDEO: HOPE-3 trial supports broader role for statins in primary prevention
MDedge Family Medicine
VIDEO: New ACC consensus guidance addresses nonstatin therapies
MDedge Family Medicine
VIDEO: Low thyroid function increases odds of type 2 diabetes
MDedge Family Medicine
FDA adds safety warnings to certain type 2 diabetes medications
MDedge Family Medicine
Morning cortisol rules out adrenal insufficiency
MDedge Family Medicine